Hormone-like behavioral effects of levonorgestrel and its metabolites in the male rat

Pharmacology Biochemistry and Behavior

Volumn 73, Issue 4, 2002, Pages 951-961

  Morali G ^a   Lemus, A E ^b,c   Munguia R ^a   Garcia G A ^d   Grillasca, I ^d   Perez Palacios G ^e  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b DEPARTAMENTO DE QUÍMICA   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^e HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

Androgenic effects of levonorgestrel; Contraceptive progestins; Levonorgestrel; Levonorgestrel metabolites; Male sexual behavior

Indexed keywords

3ALPHA LEVONORGESTREL; 3ALPHA,5ALPHA LEVONORGESTREL; 3BETA LEVONORGESTREL; 3BETA,5ALPHA TETRAHYDROLEVONORGESTREL; 5ALPHA LEVONORGESTREL; ANDROGEN; ANDROSTANOLONE; DRUG METABOLITE; ESTRADIOL; ESTROGEN; LEVONORGESTREL; UNCLASSIFIED DRUG;

ACCESSORY SEX ORGAN; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CASTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; COPULATION; DRUG EFFECT; EJACULATION; HORMONE ACTION; MALE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; SEXUAL BEHAVIOR;

ANDROGENS; ANIMALS; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; LEVONORGESTREL; MALE; RATS; RATS, WISTAR; SEXUAL BEHAVIOR, ANIMAL;

ANIMALIA;

EID: 0036828667     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(02)00946-2     Document Type: Article

References (47)

1. Ball M.J., Ashwell E., Gillmer M.D.G. Progestagen-only oral contraceptives: comparison of the metabolic effects of levonorgestrel and norethisterone. Contraception. 44:1991;223-233.
2. Beyer C., Larsson K., Pérez-Palacios G., Moralí G. Androgen structure and male sexual behavior in the castrated rat. Horm. Behav. 4:1973;99-108.
3. Bowers A., Ringold H.J., Derot E. Steroids CL. 19-nordihydrotestosterone derivatives. J. Am. Chem. Soc. 80:1958;6115-6121.
4. Brown H.C., Krifhnamurthy S. Lithium-tri-sec-butyl borohydride. A new reagent for the reduction of cyclic and bicyclic ketones with superstereo selectivity. J. Am. Chem. Soc. 94:1972;7159-7161.
5. Cabeza M., Vilchis F., Lemus A.E., Díaz de León L., Pérez-Palacios G. Molecular interactions of levonorgestrel and its 5α-reduced derivative with androgen receptors in hamster flanking organs. Steroids. 60:1995;630-635.
6. Catherino W.H., Jeng M.H., Jordan V.C. Norgestrel and gestodene stimulate breast cancer cell growth through and oestrogen receptor mediated mechanism. Br. J. Cancer. 67:1993;945-952.
7. Chávez B.A., Vilchis F., Pérez A.E., García G.A., Grillasca I., Pérez-Palacios G. Stereospecificity of the intracellular binding of norethisterone and its A-ring reduced metabolites. J. Steroid Biochem. 22:1985;121-126.
8. Cravioto M.C., Alvarado G., Canto-de-Cetina T., Bassol S., Oropeza G., Santos-Yung R., Valencia J., Palma Y., Fuziwara J.L., Navarrete T., Garza-Flores J., Pérez-Palacios G. A multicenter comparative study on the efficacy, safety, and acceptability of the contraceptive subdermal implants Norplant® and Norplant®-II. Contraception. 55:1997;359-367.
9. Dorfman R.I., Shipley R.A. Androgens, biochemistry, physiology, and clinical significance. 1956;Wiley, New York. 590 pp.
10. Etchegoyen G., Wolpert E., Galvan E., Landeros J., Pérez-Palacios G. Effects of synthetic steroid contraceptives on biliary lipid composition of normal Mexican women. Contraception. 27:1983;591-603.
11. Garza-Flores J., Hall P.E., Pérez-Palacios G. Long-acting hormonal contraceptives for women. J. Steroid Biochem. Mol. Biol. 40:1991;697-704.
12. Kuhl H. Comparative pharmacology of newer progestogens. Drugs. 51:1996;188-215.
13. Larrea F., Moctezuma O., Pérez-Palacios G. Estrogen-like effects of norethisterone on the hypothalamic pituitary unit of ovariectomized rats. J. Steroid Biochem. 20:1984;841-847.
14. Larrea F., Vilchis F., Chávez B., Pérez A.E., Garza-Flores J., Pérez-Palacios G. The metabolism of 19-nor contraceptive progestins modulates their biological activity at the neuroendocrine level. J. Steroid Biochem. 27:1987;657-663.
15. Larsson K. Features of the neuroendocrine regulation of masculine sexual behavior. Beyer C. Endocrine control of sexual behavior. 1979;77-163 Raven Press, New York.
16. Lemus A.E., Vilchis F., Damsky R., Chávez B.A., García G.A., Grillasca I., Pérez-Palacios G. Mechanism of action of levonorgestrel: in vitro metabolism and specific interactions with steroid receptors in target organs. J. Steroid Biochem. Mol. Biol. 41:1992;881-890.
17. Lemus A.E., Enríquez J., García G.A., Grillasca I., Pérez-Palacios G. 5α-reduction of norethisterone enhances its binding affinity for androgen receptors but diminishes its androgenic potency. J. Steroid Biochem. Mol. Biol. 60:1997;121-129.
18. Lemus A.E., Zaga V., Santillán R., García G.A., Grillasca I., Damián-Matsumura P., Jackson K.J., Cooney A.J., Larrea F., Pérez-Palacios G. The oestrogenic effects of gestodene, a potent contraceptive progestin, are mediated by its A-ring reduced metabolites. J. Endocrinol. 165:2000;693-702.
19. Lemus A.E., Santillán R., Damián-Matsumura P., García G.A., Grillasca I., Pérez-Palacios G. In vitro metabolism of gestodene in target organs: formation of A-ring reduced derivatives with oestrogenic activity. Eur. J. Pharmacol. 417:2001;249-256.
20. Liao S., Liang T., Fang S., Castañeda E., Shao T.-C. Steroid structure and androgenic activity. J. Biol. Chem. 248:1973;6154-6162.
21. Martini L. The 5α-reduction of testosterone in the neuroendocrine structures. Biochemical and physiological implications. Endocr. Rev. 3:1982;1-25.
22. Meisel R.L., Sachs B.D. The physiology of male sexual behavior. Knobil E., Neill J.D. The physiology of reproduction. vol. 2:1994;3-106 Raven Press, New York.
23. Montgomery D.C. Design and Analysis of Experiments. 1991;Wiley, Belmont. 537 pp.
24. Moralí G., Lemus A.E., Oropeza M.V., García G.A., Pérez-Palacios G. Induction of male sexual behavior by norethisterone: role of its A-ring reduced metabolites. Pharmacol. Biochem. Behav. 37:1990;477-484.
25. Moralí G., Lemus A.E., Munguía R., Arteaga M., Pérez-Palacios G., Sundaram K., Kumar N., Bardin C.W. Induction of male sexual behavior in the rat by 7α-methyl-19-nortestosterone, an androgen that does not undergo 5α-reduction. Biol. Reprod. 49:1993;577-581.
26. Moralí G., Oropeza M.V., Lemus A.E., Pérez-Palacios G. Mechanisms regulating male sexual behavior in the rat: role of 3α- and 3β-androstanediols. Biol. Reprod. 51:1994;562-571.
27. 3H-androstenedione by the male rat pituitary, hypothalamus, and hippocampus. Steroids. 25:1975;53-62.
28. Pérez-Palacios G., Castañeda E., Gómez-Pérez F., Pérez A.E., Gual C. In vitro metabolism of androgens in dog hypothalamus, pituitary, and limbic system. Biol. Reprod. 3:1970;205-213.
29. Pérez-Palacios G., Fernández-Aparicio M.A., Medina M., Zacarías-Villareal J., Ulloa-Aguirre A. On the mechanism of action of progestins. Acta Endocrinol. (Copenhagen). 97:1981;320-328.
30. Pérez-Palacios G., Moralí G., García G.A., Cruz M.L., Lemus A.E. Behavioral effects of synthetic progestins. Mornex R., Jaffiol C., Leclère J. Progress in endocrinology. 1993;155-159 Parthenon, Lancs.
31. Phillips A., Demarest K., Hahn D.W., Wong F., McGuire J.L. Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins. Contraception. 41:1990;399-410.
32. Piaggio G., von Hertzen H., Grimes D.A., Van Look P.F.A. Timing of emergency contraception with levonorgestrel or the Yuzpe regimen. Lancet. 353:1999;729.
33. Rebar R.W., Zeserson K. Characteristics of the new progestogens in combination oral contraceptives. Contraception. 44:1991;1-10.
34. Sachs B.D., Barfield R.J. Functional analysis of masculine copulatory behavior in the rat. Rosenblatt J.S., Hinde R.A., Shaw E., Beer C. Advances in the study of behavior. vol. 7:1972;91-154 Academic Press, New York.
35. Santillán R., Pérez-Palacios G., Reyes M., Damián-Matsumura P., García G.A., Grillasca I., Lemus A.E. Assessment of the oestrogenic activity of the contraceptive progestin levonorgestrel and its non-phenolic metabolites. Eur. J. Pharmacol. 427:2001;167-174.
36. Schoonen W.G.E.J., Joosten J.W.H., Kloosterboer H.J. Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines. J. Steroid Biochem. Mol. Biol. 55:1995;423-437.
37. Schoonen W.G.E.J., Joosten J.W.H., Kloosterboer H.J. Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast cells: II. T47D cell lines. J. Steroid Biochem. Mol. Biol. 55:1995;439-444.
38. Sivin I., Stern J. Health during prolonged use of levonorgestrel 20 μg/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. Fertil. Steril. 61:1994;70-77.
39. Smith H., Hughes G.A., Douglas G.H., Hartley D., McLoughlin B.J., Siddall J.B., Wendt G.R., Buzby G.C. Jr., Herbst D.R., Ledig K.W., McMenamin J.R., Pattison T.W., Suida J., Tokolics J., Edgren R.A., Jansen A.B.A., Gadsby B., Watson D.H.R., Phillips P.C. Totally synthetic (±)-13-alkyl-3-hydroxy and methoxy-gona-1,3,5(10)-trien-17-ones and related compounds. Experientia. 19:1963;394-396.
40. Stanczyk F.Z., Roy S. Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids. Contraception. 42:1990;67-95.
41. Still W.C., Kahan M., Mitra A. Rapid chromatographic technique for preparative separation with moderate resolution. J. Org. Chem. 43:1978;2923-2925.
42. Thau R., Jackanicz T. Contraceptive rings - a user-controlled long-acting method for family planning. Van Look P.F.A., Pérez-Palacios G. Contraceptive research and development 1984 to 1994. The road from Mexico City to Cairo and beyond. 1994;107-120 Oxford Univ. Press, Oxford.
43. Van der Burg B. Sex steroids and growth factors in mammary cancer. Acta Endocrinol. (Copenhagen). 125:1991;38-41.
44. Van der Burg B., Kalkhoven E., Isbrücker L., de Laat S.W. Effects of progestins on the proliferation of estrogen-dependent human breast cancer cells under growth factor-defined conditions. J. Steroid Biochem. Mol. Biol. 42:1992;457-465.
45. Vilchis F., Chávez B., Pérez A.E., García G.A., Angeles A., Pérez-Palacios G. Evidence that a non-aromatizable metabolite of norethisterone induces estrogen-dependent pituitary progestin receptors. J. Steroid Biochem. 24:1986;525-531.
46. Whalen R.E., Yahr P., Luttge W.G. The role of metabolism in hormonal control of sexual behavior. Adler N., Pfaff D., Goy R.W. Handbook of behavioral neurobiology. 1985;609-663 Plenum, New York.
47. World Health Organization Task force on post-ovulatory methods of fertility regulation. Randomized controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet. 352:1998;428-433.